*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach - as a primary procedure code | 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach - as a primary or secondary procedure code | |
|---|---|---|
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | 708,850 | 1,223,513 |
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | 120,918 | 260,570 |
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total Medicare Hospitalizations after Exclusion | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 885: PSYCHOSES | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 8,631 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach in DRG | 7.14 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 5.42 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 18.85 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 14.35 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $95,018,867 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $2,033 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $11,009 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $386,535,096 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $44,785 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 1.8 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 28.41 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 39.07 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 474,314 | ||||
| Total Hospitalizations with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 3,143 | ||||
| DRG Share of Total Hospitalizations | 1.44 | ||||
| % of Total ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach in DRG | 2.6 | ||||
| Avg LOS at DRG | 3.53 | ||||
| Avg LOS with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 3.41 | ||||
| Readmission Rate at DRG | 18.03 | ||||
| Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 15.34 | ||||
| Unplanned Readmission Rate at DRG | 12.55 | ||||
| Unplanned Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 11.51 | ||||
| Total Medicare payments at DRG | $2,312,733,090 | ||||
| Total Medicare payments with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $14,714,080 | ||||
| Total Medicare payment per Day at DRG | $1,380 | ||||
| Total Medicare payment per Day with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $1,374 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,876 | ||||
| Total Medicare payment per Hospitalization with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $4,682 | ||||
| Total Medicare Charges at DRG | $11,559,952,314 | ||||
| Total Medicare Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $78,090,838 | ||||
| Avg Charges at DRG | $24,372 | ||||
| Avg Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $24,846 | ||||
| Mortality Rate at DRG | 0.22 | ||||
| Mortality Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | NA | ||||
| SNF Discharge Rate at DRG | 25.96 | ||||
| SNF Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 28.83 | ||||
| Home Discharge Rate at DRG | 43.58 | ||||
| Home Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 44.51 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 443,386 | ||||
| Total Hospitalizations with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 2,801 | ||||
| DRG Share of Total Hospitalizations | 1.35 | ||||
| % of Total ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach in DRG | 2.32 | ||||
| Avg LOS at DRG | 5.27 | ||||
| Avg LOS with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 4.74 | ||||
| Readmission Rate at DRG | 21.6 | ||||
| Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 17.19 | ||||
| Unplanned Readmission Rate at DRG | 15.91 | ||||
| Unplanned Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 13.21 | ||||
| Total Medicare payments at DRG | $3,812,834,208 | ||||
| Total Medicare payments with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $22,968,640 | ||||
| Total Medicare payment per Day at DRG | $1,632 | ||||
| Total Medicare payment per Day with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $1,730 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,599 | ||||
| Total Medicare payment per Hospitalization with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $8,200 | ||||
| Total Medicare Charges at DRG | $18,110,468,211 | ||||
| Total Medicare Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $101,795,696 | ||||
| Avg Charges at DRG | $40,846 | ||||
| Avg Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $36,343 | ||||
| Mortality Rate at DRG | 3.59 | ||||
| Mortality Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 0.71 | ||||
| SNF Discharge Rate at DRG | 22.57 | ||||
| SNF Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 22.67 | ||||
| Home Discharge Rate at DRG | 40.95 | ||||
| Home Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 48.3 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 310,318 | ||||
| Total Hospitalizations with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 2,025 | ||||
| DRG Share of Total Hospitalizations | 0.94 | ||||
| % of Total ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach in DRG | 1.67 | ||||
| Avg LOS at DRG | 3.19 | ||||
| Avg LOS with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 3.19 | ||||
| Readmission Rate at DRG | 20.19 | ||||
| Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 17.17 | ||||
| Unplanned Readmission Rate at DRG | 13.62 | ||||
| Unplanned Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 12.71 | ||||
| Total Medicare payments at DRG | $1,415,392,709 | ||||
| Total Medicare payments with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $8,872,986 | ||||
| Total Medicare payment per Day at DRG | $1,431 | ||||
| Total Medicare payment per Day with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $1,374 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,561 | ||||
| Total Medicare payment per Hospitalization with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $4,382 | ||||
| Total Medicare Charges at DRG | $7,113,640,596 | ||||
| Total Medicare Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $50,401,225 | ||||
| Avg Charges at DRG | $22,924 | ||||
| Avg Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $24,889 | ||||
| Mortality Rate at DRG | 0.63 | ||||
| Mortality Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | NA | ||||
| SNF Discharge Rate at DRG | 19.76 | ||||
| SNF Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 22.32 | ||||
| Home Discharge Rate at DRG | 50.47 | ||||
| Home Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 51.31 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| RENOWN REGIONAL MEDICAL CENTER | 1155 MILL STREET | RENO | NV | 89502 | 1,921 |
| MIAMI VALLEY HOSPITAL | 1 WYOMING ST | DAYTON | OH | 45409 | 1,299 |
| BAYSTATE MEDICAL CENTER | 759 CHESTNUT ST | SPRINGFIELD | MA | 01199 | 1,239 |
| TEXAS HEALTH HARRIS METHODIST HOSPITAL FORT WORTH | 1301 PENNSYLVANIA AVE | FORT WORTH | TX | 76104 | |
| SAINT FRANCIS HOSPITAL | 6161 S YALE AVE | TULSA | OK | 74136 | |
| HENDRICK MEDICAL CENTER | 1900 PINE ST | ABILENE | TX | 79601 | |
| CARILION ROANOKE MEMORIAL HOSPITAL | 1906 BELLEVIEW AVE SE | ROANOKE | VA | 24014 | |
| ST. JOSEPHS HOSPITAL | 3001 W DR MLK JR BLVD | TAMPA | FL | 33607 | |
| NEWYORK PRESBYTERIAN - WEILL CORNELL MEDICAL CENTER | 525 E 68TH ST | NEW YORK | NY | 10021 | |
| GENESIS HOSPITAL | 2951 MAPLE AVE | ZANESVILLE | OH | 43701 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 160 |
| Dr. GEORGES S YACOUB | 3006 N. CO. RD 25A STE 102 | TROY | OH | 45373 | 150 |
| Dr. BRYAN E FLUECKIGER | 1500 N OAKLAND AVE | BOLIVAR | MO | 65613 | 149 |
| Dr. TRACY SHAWN LOPER | 2990 N SIOUX AVE | CLAREMORE | OK | 74017 | |
| Dr. DEEP AJMANI | 200 E CHESTNUT ST | LOUISVILLE | KY | 40202 | |
| Dr. GEORGE DUDLEY GROVE | 1978 INDUSTRIAL BLVD | HOUMA | LA | 70363 | |
| Dr. TAHIR AHMED | 736 BATTLEFIELD BLVD N | CHESAPEAKE | VA | 23320 | |
| Dr. WAMIQ SULTAN | 310 WOODSTOWN ROAD | SALEM | NJ | 08079 | |
| Dr. MOVSES KAZANCHYAN | 1155 MILL ST | RENO | NV | 89502 | |
| Dr. ARDEL C CAGATA | 200 E CHESTNUT ST | LOUISVILLE | KY | 40202 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 218 |
| Dr. TRACY SHAWN LOPER | 2990 N SIOUX AVE | CLAREMORE | OK | 74017 | 156 |
| Dr. GEORGES S YACOUB | 3006 N. CO. RD 25A STE 102 | TROY | OH | 45373 | 148 |
| Dr. BRYAN E FLUECKIGER | 1500 N OAKLAND AVE | BOLIVAR | MO | 65613 | |
| Dr. DEEP AJMANI | 200 E CHESTNUT ST | LOUISVILLE | KY | 40202 | |
| Dr. GEORGE DUDLEY GROVE | 1978 INDUSTRIAL BLVD | HOUMA | LA | 70363 | |
| Dr. TAHIR AHMED | 736 BATTLEFIELD BLVD N | CHESAPEAKE | VA | 23320 | |
| Dr. WAMIQ SULTAN | 310 WOODSTOWN ROAD | SALEM | NJ | 08079 | |
| Dr. ANTHONY JOHN HALAT | 800 MERCY DR | COUNCIL BLUFFS | IA | 51503 | |
| Dr. JASON FONTAN | 2809 DENNY AVE | PASCAGOULA | MS | 39581 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 885: PSYCHOSES | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 16,929 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach in DRG | 6.5 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 7.01 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 22.88 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 16.28 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $201,679,708 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $1,700 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $11,913 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $1,088,673,788 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $64,308 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 3.67 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 31.49 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 32.32 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 539,642 | ||||
| Total Hospitalizations with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 4,943 | ||||
| DRG Share of Total Hospitalizations | 1.64 | ||||
| % of Total ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach in DRG | 1.9 | ||||
| Avg LOS at DRG | 6.42 | ||||
| Avg LOS with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 5.39 | ||||
| Readmission Rate at DRG | 26.55 | ||||
| Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 22.96 | ||||
| Unplanned Readmission Rate at DRG | 20.01 | ||||
| Unplanned Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 17.25 | ||||
| Total Medicare payments at DRG | $5,267,842,463 | ||||
| Total Medicare payments with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $40,551,541 | ||||
| Total Medicare payment per Day at DRG | $1,520 | ||||
| Total Medicare payment per Day with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $1,522 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,762 | ||||
| Total Medicare payment per Hospitalization with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $8,204 | ||||
| Total Medicare Charges at DRG | $25,503,568,329 | ||||
| Total Medicare Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $212,316,141 | ||||
| Avg Charges at DRG | $47,260 | ||||
| Avg Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $42,953 | ||||
| Mortality Rate at DRG | 5.62 | ||||
| Mortality Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 1.27 | ||||
| SNF Discharge Rate at DRG | 19.26 | ||||
| SNF Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 17.24 | ||||
| Home Discharge Rate at DRG | 39.65 | ||||
| Home Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 49.81 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | ||||
| Total Hospitalizations with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 4,108 | ||||
| DRG Share of Total Hospitalizations | 1.32 | ||||
| % of Total ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach in DRG | 1.58 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 4.13 | ||||
| Readmission Rate at DRG | 22.76 | ||||
| Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 20.57 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 14.34 | ||||
| Total Medicare payments at DRG | $2,472,138,198 | ||||
| Total Medicare payments with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $23,560,371 | ||||
| Total Medicare payment per Day at DRG | $1,444 | ||||
| Total Medicare payment per Day with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $1,387 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
| Total Medicare payment per Hospitalization with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $5,735 | ||||
| Total Medicare Charges at DRG | $12,478,361,060 | ||||
| Total Medicare Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $128,290,429 | ||||
| Avg Charges at DRG | $28,735 | ||||
| Avg Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $31,229 | ||||
| Mortality Rate at DRG | 0.91 | ||||
| Mortality Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | NA | ||||
| SNF Discharge Rate at DRG | 22.02 | ||||
| SNF Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 25.27 | ||||
| Home Discharge Rate at DRG | 46.68 | ||||
| Home Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 47.49 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 408,103 | ||||
| Total Hospitalizations with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 3,363 | ||||
| DRG Share of Total Hospitalizations | 1.24 | ||||
| % of Total ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach in DRG | 1.29 | ||||
| Avg LOS at DRG | 3.52 | ||||
| Avg LOS with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 3.67 | ||||
| Readmission Rate at DRG | 17.83 | ||||
| Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 15.48 | ||||
| Unplanned Readmission Rate at DRG | 13.81 | ||||
| Unplanned Readmission Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 11.99 | ||||
| Total Medicare payments at DRG | $2,416,862,532 | ||||
| Total Medicare payments with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $19,747,469 | ||||
| Total Medicare payment per Day at DRG | $1,682 | ||||
| Total Medicare payment per Day with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $1,600 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,922 | ||||
| Total Medicare payment per Hospitalization with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $5,872 | ||||
| Total Medicare Charges at DRG | $13,267,744,847 | ||||
| Total Medicare Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $116,597,529 | ||||
| Avg Charges at DRG | $32,511 | ||||
| Avg Charges with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | $34,671 | ||||
| Mortality Rate at DRG | 0.72 | ||||
| Mortality Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 0.33 | ||||
| SNF Discharge Rate at DRG | 14.1 | ||||
| SNF Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 14.36 | ||||
| Home Discharge Rate at DRG | 62.97 | ||||
| Home Discharge Rate with ICD 3E0234Z - Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach | 65.83 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| NEWYORK PRESBYTERIAN - WEILL CORNELL MEDICAL CENTER | 525 E 68TH ST | NEW YORK | NY | 10021 | 5,154 |
| RENOWN REGIONAL MEDICAL CENTER | 1155 MILL STREET | RENO | NV | 89502 | 4,597 |
| BAYSTATE MEDICAL CENTER | 759 CHESTNUT ST | SPRINGFIELD | MA | 01199 | 2,944 |
| MIAMI VALLEY HOSPITAL | 1 WYOMING ST | DAYTON | OH | 45409 | |
| HACKENSACK UNIVERSITY MEDICAL CENTER | 30 PROSPECT AVE | HACKENSACK | NJ | 07601 | |
| TEXAS HEALTH HARRIS METHODIST HOSPITAL FORT WORTH | 1301 PENNSYLVANIA AVE | FORT WORTH | TX | 76104 | |
| SAINT FRANCIS HOSPITAL | 6161 S YALE AVE | TULSA | OK | 74136 | |
| HENDRICK MEDICAL CENTER | 1900 PINE ST | ABILENE | TX | 79601 | |
| CARILION ROANOKE MEMORIAL HOSPITAL | 1906 BELLEVIEW AVE SE | ROANOKE | VA | 24014 | |
| ST. JOSEPHS HOSPITAL | 3001 W DR MLK JR BLVD | TAMPA | FL | 33607 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 192 |
| Dr. GEORGES S YACOUB | 3006 N. CO. RD 25A STE 102 | TROY | OH | 45373 | 180 |
| Dr. BRYAN E FLUECKIGER | 1500 N OAKLAND AVE | BOLIVAR | MO | 65613 | 156 |
| Dr. TRACY SHAWN LOPER | 2990 N SIOUX AVE | CLAREMORE | OK | 74017 | |
| Dr. STEVEN D. LA VIOLA | 845 S FAIRMONT AVE | LODI | CA | 95240 | |
| Dr. DEEP AJMANI | 200 E CHESTNUT ST | LOUISVILLE | KY | 40202 | |
| Dr. TAHIR AHMED | 736 BATTLEFIELD BLVD N | CHESAPEAKE | VA | 23320 | |
| Dr. WAMIQ SULTAN | 310 WOODSTOWN ROAD | SALEM | NJ | 08079 | |
| Dr. ANTHONY JOHN HALAT | 800 MERCY DR | COUNCIL BLUFFS | IA | 51503 | |
| Dr. GEORGE DUDLEY GROVE | 1978 INDUSTRIAL BLVD | HOUMA | LA | 70363 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 497 |
| Dr. GEORGES S YACOUB | 3006 N. CO. RD 25A STE 102 | TROY | OH | 45373 | 207 |
| Dr. DEEP AJMANI | 200 E CHESTNUT ST | LOUISVILLE | KY | 40202 | 177 |
| Dr. TRACY SHAWN LOPER | 2990 N SIOUX AVE | CLAREMORE | OK | 74017 | |
| Dr. BRYAN E FLUECKIGER | 1500 N OAKLAND AVE | BOLIVAR | MO | 65613 | |
| Dr. TAHIR AHMED | 736 BATTLEFIELD BLVD N | CHESAPEAKE | VA | 23320 | |
| Dr. SAMIR JOGLEKAR | 16605 SOUTHWEST FWY | SUGAR LAND | TX | 77479 | |
| Dr. ANTHONY JOHN HALAT | 800 MERCY DR | COUNCIL BLUFFS | IA | 51503 | |
| Dr. THI KHOA NGUYEN | 1745 E GLENN ST APT 215 | TUCSON | AZ | 85719 | |
| Dr. JAMES CHARLES MCMASTER | 501 S 54TH STREET | PHILADELPHIA | PA | 19143 |